相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The p53 tumor suppressor: A master regulator of diverse cellular processes and therapeutic target in cancer
Marianne Farnebo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Reactivation of p53 by Novel MDM2 Inhibitors: Implications for Pancreatic Cancer Therapy
A. S. Azmi et al.
CURRENT CANCER DRUG TARGETS (2010)
MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 function
Asfar S. Azmi et al.
EUROPEAN JOURNAL OF CANCER (2010)
MDM2 SNP309 Associates With Accelerated Pancreatic Adenocarcinoma Formation
Lukasz F. Grochola et al.
PANCREAS (2010)
Small-molecule inhibitors of MDM2 as new anticancer therapeutics
Michael P. Dickens et al.
SEMINARS IN CANCER BIOLOGY (2010)
Cytoplasmic tethering is involved in synergistic inhibition of p53 by Mdmx and Mdm2
Chihiro Ohtsubo et al.
CANCER SCIENCE (2009)
Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy
Sanjeev Shangary et al.
Annual Review of Pharmacology and Toxicology (2008)
Polysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 Testing
Isabelle Vanden Bempt et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms
Joshua Weaver et al.
MODERN PATHOLOGY (2008)
MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancers
Ann Forslund et al.
MOLECULAR CANCER RESEARCH (2008)
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
Sanjeev Shangary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Restoration of p53 function leads to tumour regression in vivo
Andrea Ventura et al.
NATURE (2007)
MDM2 inhibitors for cancer therapy
Lyubomir T. Vassilev
TRENDS IN MOLECULAR MEDICINE (2007)
MDM2 SNP309 accelerates colorectal tumour formation in women
Gareth L. Bond et al.
JOURNAL OF MEDICAL GENETICS (2006)
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner
Gareth L. Bond et al.
CANCER RESEARCH (2006)
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy
C Tovar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
GL Bond et al.
CELL (2004)
The clinicopathological features and importance of p53, Rb, and mdm2 expression in phaeochromocytomas and paragangliomas
KY Lam et al.
JOURNAL OF CLINICAL PATHOLOGY (2001)
Analysis of mdm2 and p53 gene alterations in glioblastomas and its correlation with clinical factors
M Schiebe et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
分享论文
